XML 28 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

 

7. INCOME TAXES

 

The following table reconciles the United States statutory income tax rate with our effective income tax rate:

 

 

 

 

Year ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

United States statutory rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

State tax, net of federal benefit

 

 

4.2

%

 

 

1.0

%

 

 

0.7

%

Stock-based compensation

 

 

(0.5

%)

 

 

(1.6

%)

 

 

3.6

%

Officer compensation

 

 

(1.0

%)

 

 

(1.3

%)

 

 

%

Deferred rate change

 

 

%

 

 

%

 

 

0.3

%

R&D credit

 

 

0.8

%

 

 

1.8

%

 

 

0.7

%

Other

 

 

(0.1

)%

 

 

0.3

%

 

 

0.7

%

Change in valuation allowance

 

 

(24.4

%)

 

 

(21.2

%)

 

 

(27.0

%)

Effective income tax rate

 

 

%

 

 

%

 

 

%

 

 

Deferred assets and liabilities consist of the following:

 

 

 

December 31,

 

In Thousands

 

2020

 

 

2019

 

 

2018

 

Net operating losses

 

$

33,392

 

 

$

24,852

 

 

$

16,372

 

Stock-based compensation

 

 

2,531

 

 

 

3,637

 

 

 

2,747

 

Financing lease obligations

 

 

4,574

 

 

 

4,640

 

 

 

4,009

 

Tax credit carry forwards

 

 

2,577

 

 

 

2,106

 

 

 

922

 

Compensation

 

 

339

 

 

 

97

 

 

 

474

 

Derivative liability

 

 

703

 

 

 

 

 

 

 

Other

 

 

391

 

 

 

307

 

 

 

116

 

Gross deferred tax assets

 

 

44,507

 

 

 

35,639

 

 

 

24,640

 

Less valuation allowance

 

 

(39,898

)

 

 

(30,888

)

 

 

(20,329

)

Net deferred tax assets

 

 

4,609

 

 

 

4,751

 

 

 

4,311

 

Fixed assets

 

 

(4,609

)

 

 

(4,746

)

 

 

(4,352

)

Other

 

 

 

 

 

(5

)

 

 

41

 

Gross deferred tax liabilities

 

 

(4,609

)

 

 

(4,751

)

 

 

(4,311

)

Net deferred tax asset or liability

 

$

 

 

$

 

 

$

 

 

We provide for a valuation allowance when it is more likely than not that we will not realize a portion of the deferred tax assets. We have established a full valuation allowance for deferred tax assets described above due to the uncertainty that enough taxable income will be generated in the taxing jurisdiction to utilize the assets. Therefore, we have not reflected any benefit of such deferred tax assets in the accompanying consolidated financial statements

 

We have $206.1 million of tax loss carryforwards. Of this amount, $64.0 million are state operating loss carryforwards and $142.1 million are federal operating loss carryforwards. The federal carryforward periods are as follows: $100.2 million do not expire and $41.9 million expire between 2032 and 2037. The state net operating losses will expire between 2027 and 2037, with some amounts having indefinite carryover. We also have federal and state R&D credit carryovers of $1.9 million and $0.9 million, which will expire between 2032 and 2037.

 

We are subject to federal income taxes in the United States as well as various state and local jurisdictions. Several years may elapse before an uncertain tax position is audited and finally resolved. While it is often difficult to predict the outcome or the timing of resolution of any uncertain tax position, we do not believe that we need to recognize any liabilities for uncertain tax positions as of December 31, 2020. We will classify any future interest and penalties as a component of income tax expense if incurred.

 

We do not expect the amount of uncertain tax positions to change significantly in the next twelve months. Our major taxing jurisdictions are in the United States, at both the federal and state levels. The number of years open for examination varies depending on the tax jurisdiction, but are generally from 3 to 5 years.